Clinical Trial Update: Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing lamivudine and entecavir for spontaneous severe acute exacerbation in chronic hepatitis B has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Lamivudine (lamivudine)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Chronic Hepatitis B | Phase 4 | Status: TERMINATED